40 related articles for article (PubMed ID: 9207466)
1. Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia.
Zhu J; Koken MH; Quignon F; Chelbi-Alix MK; Degos L; Wang ZY; Chen Z; de Thé H
Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3978-83. PubMed ID: 9108090
[TBL] [Abstract][Full Text] [Related]
2. [Detection of PML/RARalpha gene transcripts in 46 newly diagnosed acute promyelocytic leukemia patients by real-time quantitative reverse-transcription polymerase chain reaction].
Zhu HH; Liu YR; Qin YZ; Li JL; Chang Y; Wang YZ; Shan FX; Jiang B; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):1-5. PubMed ID: 17490509
[TBL] [Abstract][Full Text] [Related]
3. A protease-resistant PML-RAR{alpha} has increased leukemogenic potential in a murine model of acute promyelocytic leukemia.
Uy GL; Lane AA; Welch JS; Grieselhuber NR; Payton JE; Ley TJ
Blood; 2010 Nov; 116(18):3604-10. PubMed ID: 20647568
[TBL] [Abstract][Full Text] [Related]
4. PML(NLS(-)) inhibits cell apoptosis and promotes proliferation in HL-60 cells.
Gao YM; Zhong L; Zhang X; Hu XX; Liu BZ
Int J Med Sci; 2013; 10(5):498-507. PubMed ID: 23532460
[TBL] [Abstract][Full Text] [Related]
5. The biological characteristics of adult CD34+ acute promyelocytic leukemia.
Ahmad EI; Akl HKh; Hashem ME; Elgohary TA
Med Oncol; 2012 Jun; 29(2):1119-26. PubMed ID: 21399995
[TBL] [Abstract][Full Text] [Related]
6. The transcriptome-wide landscape of molecular subtype-specific mRNA expression profiles in acute myeloid leukemia.
Mou T; Pawitan Y; Stahl M; Vesterlund M; Deng W; Jafari R; Bohlin A; Österroos A; Siavelis L; Bäckvall H; Erkers T; Kiviluoto S; Seashore-Ludlow B; Östling P; Orre LM; Kallioniemi O; Lehmann S; Lehtiö J; Vu TN
Am J Hematol; 2021 May; 96(5):580-588. PubMed ID: 33625756
[TBL] [Abstract][Full Text] [Related]
7. Acute Promyelocytic Leukemia with t(2;3): An Unusual Additional Chromosomal Abnormality.
Gajendra S; Yadav AK; Bhargava M
Indian J Hematol Blood Transfus; 2022 Jan; 38(1):202-203. PubMed ID: 35125731
[TBL] [Abstract][Full Text] [Related]
8. Leukaemia cutis for clinicians, a literature review.
Osmola M; Gierej B; Kłosowicz A; Waszczuk-Gajda A; Basak GW; Jędrzejczak WW; Jurczyszyn A; Ziarkiewicz-Wróblewska B
Postepy Dermatol Alergol; 2021 Jun; 38(3):359-365. PubMed ID: 34377113
[TBL] [Abstract][Full Text] [Related]
9. Expression of a bcr-1 isoform of RARalpha-PML does not affect the penetrance of acute promyelocytic leukemia or the acquisition of an interstitial deletion on mouse chromosome 2.
Walter MJ; Ries RE; Armstrong JR; Park JS; Mardis ER; Ley TJ
Blood; 2007 Feb; 109(3):1237-40. PubMed ID: 17008533
[TBL] [Abstract][Full Text] [Related]
10. Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice.
Zimonjic DB; Pollock JL; Westervelt P; Popescu NC; Ley TJ
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13306-11. PubMed ID: 11087871
[TBL] [Abstract][Full Text] [Related]
11. A bcr-3 isoform of RARalpha-PML potentiates the development of PML-RARalpha-driven acute promyelocytic leukemia.
Pollock JL; Westervelt P; Kurichety AK; Pelicci PG; Grisolano JL; Ley TJ
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15103-8. PubMed ID: 10611345
[TBL] [Abstract][Full Text] [Related]
12. The PML/RAR alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells.
Raelson JV; Nervi C; Rosenauer A; Benedetti L; Monczak Y; Pearson M; Pelicci PG; Miller WH
Blood; 1996 Oct; 88(8):2826-32. PubMed ID: 8874178
[TBL] [Abstract][Full Text] [Related]
13. Characterization of acute promyelocytic leukemia cases with PML-RAR alpha break/fusion sites in PML exon 6: identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid.
Gallagher RE; Li YP; Rao S; Paietta E; Andersen J; Etkind P; Bennett JM; Tallman MS; Wiernik PH
Blood; 1995 Aug; 86(4):1540-7. PubMed ID: 7632962
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.
Grimwade D; Solomon E
Curr Top Microbiol Immunol; 1997; 220():81-112. PubMed ID: 9103677
[TBL] [Abstract][Full Text] [Related]
15. The molecular biology of acute promyelocytic leukemia.
Slack JL; Gallagher RE
Cancer Treat Res; 1999; 99():75-124. PubMed ID: 9891864
[TBL] [Abstract][Full Text] [Related]
16. RAR alpha1/RAR alpha2-PML mRNA expression in acute promyelocytic leukemia cells: a molecular and laboratory-clinical correlative study.
Li YP; Andersen J; Zelent A; Rao S; Paietta E; Tallman MS; Wiernik PH; Gallagher RE
Blood; 1997 Jul; 90(1):306-12. PubMed ID: 9207466
[TBL] [Abstract][Full Text] [Related]
17. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
